tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS

Syros Pharmaceuticals (SYRS) Balance Sheet

872 Followers

Syros Pharmaceuticals Balance Sheet

Syros Pharmaceuticals's total assets for Q4 2023 were $168.17M, an increase of 13.79% from the previous quarter. SYRS total liabilities were $151.51M for the fiscal quarter, a 35.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 168.17M$ 244.49M$ 182.94M$ 213.25M$ 149.98M
Total Liabilities
$ 151.51M$ 116.75M$ 97.72M$ 122.70M$ 70.79M
Total Equity Gross Minority
$ 16.67M$ 127.77M$ 85.22M$ 90.55M$ 79.18M
Total Capitalization
$ 104.30M$ 229.88M$ 125.47M$ 130.10M$ 79.18M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 26.66M$ 25.92M
Currency in USD

Syros Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis